Insulet PODD
Jump To Section
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Insulet (PODD) Business Model and Operations Summary
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Key Insights
Insulet (PODD) Core Market Data and Business Metrics
Latest Closing Price
$291.49Market Cap
$21.65 BillionAverage Daily Volume
885,936 Shares52-Week Range
$173.00-$329.33Total Outstanding Shares
70.37 Million SharesCEO
Ms. Ashley A. McEvoyTotal Employees
3,900Current Dividend
No dividendIPO Date
May 15, 2007SIC Description
Surgical & Medical Instruments & ApparatusHeadquarters
100 Nagog Park, Acton, MA, 01720